Congenital heart disease patients with extremely complex three-dimensional structure of the heart. congenital heart disease
Conditions
Interventions
To simulate and suggest to surgeons the postoperative hemodynamics of multiple possible surgical
techniques based on preoperative cardiac morphology and hemodynamics.
Sponsors
Kurosaki Kenichi
Hisada Toshiaki
PIA Co.,Ltd
Japan Medical Device Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with pediatric congenital heart disease requiring life-sustaining cardiac repair surgery. (2) Patients under 15 years of age (when consent is obtained from a substitute). (3) Patients who need to undergo cardiac catheterization, cardiovascular angiography, and MSCT angiography to determine the diagnosis and treatment plan. (4) Patients scheduled to undergo surgery for congenital heart disease within 180 days of obtaining consent. (5) Patients with the following congenital heart diseases in which the three-dimensional structure of the heart and great vessels are extremely complicated. 1. Double outlet right ventricle 2. Complete transposition of the great arteries 3. Congenitally corrected transposition of the great arteries 4. Coarctation of aorta/ Interrupted aortic arch 5. Ventricular septal defect with multiple defects 6. Univentricular Heart (including complete atrioventricular septal defect with unbalanced ventricles) 7. Tetralogy of Fallot with or without pulmonary atresia 8. Hypoplastic left heart syndrome and its analogs
Exclusion criteria
Exclusion criteria: (1) Critically ill patients who may require urgent cardiac repair surgery before the simulation using the ped UT-Heart system is available. (2) Patients who are allergic to contrast media used in MSCT and cardiac catheterization/angiography. (3) Patients for whom follow-up until 30 days after surgery is difficult. (4) Patients who are judged by the principal investigator to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall postoperative evaluation of the usefulness of ped UT-Heart in assisting in the choice of procedure as assessed by the surgeon (Essential or Very useful on the Likert scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. survival rate at 30 days after surgery 2. length of stay in ICU 3. presence and duration of assisted circulation in ICU 4. cardiac arrest time in surgery 5. cardiopulmonary resuscitation time in surgery 6. reoperation or not 7. catheterization or not 8. changes in the results of cross-sectional echocardiography (preoperative and 30-day postoperative comparison) 9. assessment of neurological development at 30 days postoperatively (if performed) | — |
Contacts
Public ContactIsao Shiraishi
National Cerebral and Cardiovascular Center
Outcome results
None listed